Array BioPharma Inc. Forecast and Stock Analysis
Technical ARRY stock analysis for April 24, 2019.
Array BioPharma Inc. fell by -0.52% in the last day from $22.92 to $22.80 The price has fallen in 7 of the last 10 days and is down by -5.63% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -1.16 million shares and in total 1.27 million shares bought and sold for approximately $28.99 million.
Close price at the end of the last trading day (Wednesday, 24th Apr 2019) of the ARRY stock was $22.80. This is 0.52% less than the trading day before Tuesday, 23rd Apr 2019.
During day the stock fluctuated 2.42% from a day low at $22.55 to a day high of $23.10.
30 day high of the ARRY stock price was $25.05 and low was $21.93.
90 day high was $25.05 and low was $16.97.
52 week high for the Array BioPharma Inc. - $25.05 and low - $12.56.
Array BioPharma Inc. lies in the lower part of a wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $22.46 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 19.49% during the next 3 months and, with 90% probability hold a price between $26.84 and $31.77 at the end of this period.
There are few to none technical positive signals at the moment. Array BioPharma Inc. holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $22.83 and $23.54. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday April 23, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
The stock currently holds a RSI14 at 27 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $21.56 and $21.29.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Array BioPharma Inc. finds support just below today's level at $21.56. If this is broken, then the next support from accumulated volume will be at $21.29 and $20.96.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.54 (2.42%) between high and low. For the last week, the stock has had a daily average volatility of 3.90%.
Array BioPharma Inc. is oversold on RSI14 (27). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
The Array BioPharma Inc. stock holds several negative signals and despite the positive trend we believe Array BioPharma Inc. will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|ARRY $22.80 ($-0.12 -0.52%)|
ARRY is down $0.12 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ARRY based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ARRY analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us